Bright Minds Biosciences (DRUG) Current Leases (2022 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Current Leases came in at $59889.7 in Q1 2026, up 10.53% YoY from $54185.3 in Q1 2025, and down 5.26% on a QoQ basis from $63215.5 in Q4 2025.
Bright Minds Biosciences (DRUG) Current Leases (2022 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 5 years of Current Leases data on file, last reported at $59889.7 in Q1 2026.
- Quarterly Current Leases rose 10.53% year-over-year to $59889.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59889.7 (up 10.53% YoY) and the FY2025 annual result came in at $61421.0, up 5.55% from the prior year.
- Current Leases eased to $59889.7 in Q1 2026, from $63215.5 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $63215.5 in Q4 2025 to a low of $10247.7 in Q2 2024.
- A 5-year average of $50130.1 and a median of $54433.5 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 82.21% — and 2025, when it jumped 450.65%.
- Tracing DRUG's Current Leases over 5 years: stood at $51505.8 in 2022, then decreased by 22.19% to $40078.5 in 2023, then advanced by 29.79% to $52017.2 in 2024, then advanced by 21.53% to $63215.5 in 2025, then decreased by 5.26% to $59889.7 in 2026.
- The last three Current Leases figures came in at $59889.7 (Q1 2026), $63215.5 (Q4 2025), and $61421.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | 59,889.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,889.66 |
| Dec 31, 2025 | 63,215.46 |
| Sep 30, 2025 | 61,421.00 |
| Jun 30, 2025 | 56,429.26 |
| Mar 31, 2025 | 54,185.26 |
| Dec 31, 2024 | 52,017.18 |
| Sep 30, 2024 | 58,192.71 |
| Jun 30, 2024 | 10,247.67 |
| Mar 31, 2024 | 25,775.08 |
| Dec 31, 2023 | 40,078.46 |
| Sep 30, 2023 | 54,862.44 |
| Jun 30, 2023 | 57,614.67 |
| Mar 31, 2023 | 54,433.52 |
| Dec 31, 2022 | 51,505.85 |
| Sep 30, 2022 | 52,083.54 |